FDA Approves Targeted Drug Combo for Lung Cancer FDA Approves Targeted Drug Combo for Lung Cancer

For the first time, the FDA has approved treatment for metastatic non-small cell lung cancer with BRAF V600E mutation.FDA Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news